Titan Biotech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 40.21 | 43.74 | 40.40 |
| Operating Expense | 32.13 | 34.87 | 32.84 |
| Net Profit | 5 | 5.70 | 4.84 |
| Net Profit Margin | 12.43 | 13.03 | 11.98 |
| Earning Per Share | 6.05 | 6.90 | 5.86 |
| EBIDTA | 8 | 8.88 | 7.49 |
| Effective Tax Rate | 20.17 | 20.52 | 19.44 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 40.21 |
| Operating Expense | 32.13 |
| Net Profit | 5.00 |
| Net Profit Margin | 12.43 |
| Earning Per Share | 6.05 |
| EBIDTA | 8.00 |
| Effective Tax Rate | 20.17 |
Invest in Titan Biotech Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 164.07 | 144.00 | 123.55 |
| Operating Expenses Annual | 129.79 | 114.48 | 92.28 |
| Operating Profit Annual | 36.03 | 31.46 | 32.21 |
| Interest Annual | 1.17 | 0.75 | 0.87 |
| Depreciation | 2.84 | 2.12 | 2.35 |
| Net Profit Annual | 23.66 | 21.02 | 21.68 |
| Tax Annual | 7.87 | 7.09 | 7.28 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 164.07 |
| Operating Expenses Annual | 129.79 |
| Operating Profit Annual | 36.03 |
| Interest Annual | 1.17 |
| Depreciation | 2.84 |
| Net Profit Annual | 23.66 |
| Tax Annual | 7.87 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 4.86 | 6.81 | 5.31 |
| Cash Flow from Operations | 21.15 | 21.18 | 22.04 |
| Cash Flow from Investing | -20.30 | -20.73 | -16.44 |
| Cash Flow from Financing | -2.87 | -2.40 | -4.10 |
| Cash Flow at the End | 2.84 | 4.86 | 6.81 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 4.86 |
| Cash Flow from Operations | 21.15 |
| Cash Flow from Investing | -20.30 |
| Cash Flow from Financing | -2.87 |
| Cash Flow at the End | 2.84 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 21.96 | 21.85 | 26.07 |
| PBIT Margin (%) | 19.93 | 20.05 | 24.15 |
| PBT Margin (%) | 2.89 | -6.67 | -3.60 |
| Net PROFIT Margin (%) | 14.42 | 14.60 | 17.55 |
| Return On Networth / Equity (%) | 20.18 | 21.86 | 28.52 |
| Return On Networth /Employed (%) | 25.70 | 27.12 | 34.30 |
| Return On Assets (%) | 18.60 | 19.71 | 24.92 |
| Total Debt / Equity (X) | 0.07 | 0.09 | 0.13 |
| Asset Turnover Ratio (%) | 1.29 | 1.35 | 1.42 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 21.96 |
| PBIT Margin (%) | 19.93 |
| PBT Margin (%) | 2.89 |
| Net PROFIT Margin (%) | 14.42 |
| Return On Networth / Equity (%) | 20.18 |
| Return On Networth /Employed (%) | 25.70 |
| Return On Assets (%) | 18.60 |
| Total Debt / Equity (X) | 0.07 |
| Asset Turnover Ratio (%) | 1.29 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 52.03 | 35.89 | 34.99 |
| Total Current Assets Annual | 72.17 | 68.31 | 63.76 |
| Non Current Assets Annual | 79.40 | 62.39 | 44.34 |
| Total Shareholders Funds Annual | 128.44 | 106.09 | 86.24 |
| Total Assets Annual | 151.57 | 130.70 | 108.09 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 52.03 |
| Total Current Assets Annual | 72.17 |
| Non Current Assets Annual | 79.40 |
| Total Shareholders Funds Annual | 128.44 |
| Total Assets Annual | 151.57 |
EPS (INR)
Expected
8.11
Reported
8.10
Surprise
-0.12%
Jun 2024
EPS beaten by -0.12%
Mar 2024
EPS beaten by -0.13%
Dec 2023
EPS beaten by 0.00%
